Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...

Latanoprost ophthalmic solution 0.005% with 0.02% BAK or travoprost 0.004% ophthalmic solution with sofZia were tested against the following bacteria and fungi: Staphylococcus aureus (ATCC 6538 ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

30 days Prescribing information Latanoprost 0.005% ophthalmic solution Xalatan (Pharmacia and Upjohn) 6 wk Prescribing information Lopinavir/ritonavir capsules Kaletra capsules (Abbott ...

Medication is not always necessary or the best choice for treating a vision problem, and sometimes, medication isn't an option at all. But in many cases, it can certainly help with vision problems, ...

We present a case of unilateral, secondary open-angle glaucoma due to an underlying diffuse iris melanoma. The patient was referred by his ophthalmologist with uncontrolled, elevated intraocular ...

Experimental studies, animal studies and randomised studies with other intraocular pressure-lowering eye drops were excluded ... A higher frequency of both uveitis and CME were found among latanoprost ...